![](/img/cover-not-exists.png)
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure
Armstrong, April, Paul, Carle, Puig, Luis, Boehncke, Wolf Henning, Freeman, Michael, Torii, Hideshi, Papp, Kim, Griffiths, Christopher E. M., Blauvelt, Andrew, Reich, Kristian, Gooderham, Melinda, TerLanguage:
english
Journal:
Dermatology and Therapy
DOI:
10.1007/s13555-019-00340-3
Date:
November, 2019
File:
PDF, 518 KB
english, 2019